| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/07/2007 | WO2007048027A3 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 06/07/2007 | WO2007041076A3 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 06/07/2007 | WO2007035367B1 Northern white kidney bean extract and red kidney bean extract in combination with green tea extract in the treatment of obesity |
| 06/07/2007 | WO2007028633A3 Treatment of diabetes related obesity |
| 06/07/2007 | WO2007024472A3 USE OF PAR- l/PAR- 4 INHIBITORS FOR TREATING OR PREVENTING VASCULAR DISEASES |
| 06/07/2007 | WO2007010281A3 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 06/07/2007 | US20070129440 Polypharmacophoric agents |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129346 Melanocortin receptor agonists |
| 06/07/2007 | US20070129291 Genobix agonists and antagonists for use in the treatment of metabolic disorders |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128176 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 06/07/2007 | CA2631549A1 Polymorphs of [r-(r*, r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-lh-pyrrole-l-heptanoic acid magnesium salt (2: 1) |
| 06/07/2007 | CA2630513A1 Dog diabetes |
| 06/07/2007 | CA2630460A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 06/07/2007 | CA2630314A1 1,5-substituted indol-2-yl amide derivatives |
| 06/07/2007 | CA2630307A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 06/07/2007 | CA2614340A1 Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2) |
| 06/06/2007 | EP1793000A1 Transgenically produced non-secreted proteins |
| 06/06/2007 | EP1792983A1 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiences thereof |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1792629A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 06/06/2007 | EP1792626A1 Treatment of obesity by brain delivery of alpha-MSH and analogs thereof |
| 06/06/2007 | EP1792616A1 Composition comprising an HMG-CoA inhibitor and a nicotinic acid compound for treating hyperlipidemia |
| 06/06/2007 | EP1791844A1 8-(3-amino-piperidin-1-yl)-7-(but-2-inyl)-xanthines, production thereof and use thereof as medicaments |
| 06/06/2007 | EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/06/2007 | EP1791817A1 Dpp-iv inhibitors |
| 06/06/2007 | EP1791600A1 Combination of organic compounds |
| 06/06/2007 | EP1791568A2 Therapeutic uses of inhibitors of rtp801 |
| 06/06/2007 | EP1791554A2 Pharmaceutical compositions containing insulin and insulinotropic peptide |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1791536A1 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 06/06/2007 | EP1619962B1 Composition for oral administration containing capsaicinoids |
| 06/06/2007 | EP1496894A4 Angiogenesis inhibitors |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1289556B1 Isoflavones against radiation-induced mortality |
| 06/06/2007 | EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| 06/06/2007 | EP0920446B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/06/2007 | EP0862625B1 Methods for modulation of cholesterol transport |
| 06/06/2007 | EP0839039B2 Paroxetine controlled release compositions |
| 06/06/2007 | CN1976948A 修饰的Exendins及其应用 Modified Exendins Its Applications |
| 06/06/2007 | CN1976910A Novel 2,4-diaminothiazol-5-one derivatives |
| 06/06/2007 | CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 06/06/2007 | CN1976714A Composition comprising fermented tea extract as the main component and having effect of increasing adiponectin |
| 06/06/2007 | CN1976696A Pharmaceutical composition for prevention or treatment of lipid metabolism disorder |
| 06/06/2007 | CN1976691A Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/06/2007 | CN1976682A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active component |
| 06/06/2007 | CN1974603A Alpha-glucosan originated from ash tree flower sporophore and its prepn process and use |
| 06/06/2007 | CN1974569A 8-octyl berberine hydrochloride and its synthesis process and application |
| 06/06/2007 | CN1973877A Calamus effective-part extract and its use |
| 06/06/2007 | CN1973875A Process of extracting Tatine compounds from Puer tea and the product |
| 06/06/2007 | CN1973845A Blood sugar reducing component of kelp root and its prepn process |
| 06/06/2007 | CN1973842A Tetracyclic fat reducing and slimming prepn and its production process |
| 06/06/2007 | CN1973829A Process of preparing calcitonin microsphere |
| 06/06/2007 | CN1973687A Health oyster-turtle powder |
| 06/06/2007 | CN1973686A Natural beverage liquid with functions of lowering cholesterol and regulating blood fat and its prepn process |
| 06/06/2007 | CN1973683A Health food and its production process |
| 06/06/2007 | CN1973682A Health food |
| 06/06/2007 | CN1973681A Technological process of producing oat diet fiber and nutritious powder with oat bran |
| 06/06/2007 | CN1973676A Pear ball making process |
| 06/06/2007 | CN1973671A Production process of microwave modified oat fiber powder |
| 06/06/2007 | CN1973662A Chinese herbal medicine type green concentrated feed for raising fattening pig |
| 06/06/2007 | CN1973657A Process of preparing nutrient solution for animal |
| 06/06/2007 | CN1973653A Prepn process and application of instant Pu'er tea granule |
| 06/06/2007 | CN1973635A Sugar-free biscuit and its production process |
| 06/06/2007 | CN1320121C Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| 06/06/2007 | CN1319992C Preparation process and application of Chinese yam starch |
| 06/06/2007 | CN1319968C Compositions useful as inhibitors of GSK-3 |
| 06/06/2007 | CN1319963C Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/06/2007 | CN1319959C Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/06/2007 | CN1319957C Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 06/06/2007 | CN1319956C Thiazolidine diketone derivatives, preparing process and application of pharmaceutical preparations of the same |
| 06/06/2007 | CN1319950C 3-substituted-4-pyrimidone derivatives |
| 06/06/2007 | CN1319945C Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 06/06/2007 | CN1319938C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 06/06/2007 | CN1319594C Oxynthomodulin for preventing or treating excess weight |
| 06/06/2007 | CN1319588C Theory and medicine for treating high blood fat, fatty liver, liver fibrosis and preparation method |
| 06/06/2007 | CN1319578C Chinese medicine compound preparation, its preparation method and use |
| 06/06/2007 | CN1319539C Medicinal composition with synergetic function |
| 06/06/2007 | CN1319532C Use of N-(indolecarbonyl-)piperazine derivatives |
| 06/06/2007 | CN1319472C Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase intramyocellular lipid level |
| 06/06/2007 | CN1319468C Product for feeding paste to body system |
| 06/05/2007 | USRE39682 Enzyme inhibitors, for cancer therapy |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 06/05/2007 | US7227033 Crystalline polymorph of the anhydrous form in synergistic combination with another active ingredient to enhance drug delivery; antidiabetic agents |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders |
| 06/05/2007 | US7227014 Oligonucleotide with 8-50 bases specifically hybridizes with a nucleic acid molecule encoding human apolipoprotein(a) and inhibits its expression |
| 06/05/2007 | US7226990 Extendin derivatives |
| 06/05/2007 | US7226943 Antilipemic agents |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 06/05/2007 | US7226935 Hypoglycemic agent |
| 06/05/2007 | US7226785 A single-stranded oligonucleotide with a DNA domain having at least one mismatch with respect to genetic sequence to be altered |
| 06/05/2007 | US7226618 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 06/05/2007 | CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/05/2007 | CA2385083C O-anisamide derivatives |
| 06/05/2007 | CA2376094C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (ppar) .alpha. |
| 06/05/2007 | CA2294385C Treatment of diabetes with thiazolidinedione and sulphonylurea |